Ph Positive ALL
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Long-term Progression of Patients Treated and Monitored for Relapsed or Refractory Ph+ ALL (NCT07433400) | Group for Research in Adult Acute Lymphoblastic Leukemia | 2025-08-29 |
| Dasatinib Plus Anti-CD19/CD22 Bispecific CAR-T Cell Therapy for Elderly Ph-positive ALL Patients (NCT05523661) | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | 2021-03-01 |
Track Ph Positive ALL automatically
Every clearance here is in the API, with alerts when new ones post.